Breaking News Instant updates and real-time market news.

XENT

Intersect ENT

$16.60

0.1 (0.61%)

08:03
10/17/16
10/17
08:03
10/17/16
08:03

Intersect ENT reports RESOLVE II study met both primary efficacy endpoints

Intersect ENT announced results from RESOLVE II, a randomized, blinded, multi-center clinical trial designed to assess the safety and efficacy of the company's investigational RESOLVE steroid releasing implant. The RESOLVE II pivotal phase III study evaluated the implant in 300 adult chronic sinusitis patients, all of whom were indicated for revision sinus surgery at study entry due to recurrent symptoms and obstructive inflammation. Patients were randomized to one of two groups: a treatment group consisting of bilateral RESOLVE implant placement in the office, or a control group consisting of a sham procedure. The study met both co-primary efficacy endpoints. An independent panel of surgeons blinded to treatment assignment evaluated the change in mean bilateral polyp grade from baseline to day 90 based on video endoscopies. A statistically significant difference in mean change from baseline favoring the treatment group was observed. The change in mean Nasal Obstruction/Congestion score was measured from baseline to day 30, as scored by patients using a daily diary. A statistically significant difference in mean change from baseline favoring the treatment group was observed. Secondary endpoints achieving statistical significance through day 90 include the proportion of patients still indicated for repeat sinus surgery and improvements in sense of smell, sense of nasal obstruction, and total symptom score. Safety was evaluated by endoscopic examination and evaluation of adverse events. One serious device-related adverse event, an intranasal bleed requiring intervention, was observed. Intersect ENT plans to submit a New Drug Application, or NDA, in the first quarter of 2017 for regulatory approval from the U.S. FDA to market the RESOLVE product.

  • 17

    Nov

  • 29

    Nov

XENT Intersect ENT
$16.60

0.1 (0.61%)

05/06/16
WEDB
05/06/16
NO CHANGE
WEDB
Intersect ENT post-earnings weakness an overreaction, says Wedbush
Wedbush believes that nothing has really changed in the story for Intersect ENT based on the company's quarterly report and thinks today's selloff is an overreaction.
05/20/16
PIPR
05/20/16
NO CHANGE
Target $23
PIPR
Overweight
Intersect ENT selloff feels like an overreaction, says Piper Jaffray
After meeting with Intersect ENT's CEO Lisa Earnhardt, Piper Jaffray analyst Matt O'Brien says the recent pullback in the shares "feels like a bit of an overreaction." The company's sales force has stabilized and Q2 and Q3 revenue estimates look achievable, O'Brien tells investors in a research note. Further, with $4 per share in cash and no debt, Intersect's current stock price implies little, if any, value to its pipeline of products, the analyst argues. He keeps an Overweight rating on the shares with a $23 price target.
08/25/16
PIPR
08/25/16
NO CHANGE
PIPR
Intersect ENT should be owned at current levels, says Piper Jaffray
After meeting with Intersect's management, Piper Jaffray analyst Matt O'Brien says that recent "negative issues" involving sales force disruptions and reimbursement are not "hurting the company much." The analyst says that the company has several growth drivers, and he predicts that they will enable the company's revenue to increase about 20% over the next several years. O'Brien says that the decline in the stock this year is overdone, and he keeps a $21 price target and Overweight rating on the shares.
10/06/16
DBAB
10/06/16
INITIATION
Target $17
DBAB
Hold
Intersect ENT initiated with a Hold at Deutsche Bank
Deutsche Bank analyst Brittany Henderson started Intersect ENT with a Hold rating and $17 price target. The analyst believes risk around the company's execution and reimbursement offsets its differentiated product platform in the near term.

TODAY'S FREE FLY STORIES

UTX

United Technologies

$112.09

-0.57 (-0.51%)

18:32
02/23/17
02/23
18:32
02/23/17
18:32
Hot Stocks
Carrier expands air conditioner, heat pump recall »

United Technologies'…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

BREW

Craft Brew

$15.60

-0.25 (-1.58%)

, BUD

AB InBev

$108.76

-0.4 (-0.37%)

18:17
02/23/17
02/23
18:17
02/23/17
18:17
Hot Stocks
Craft Brew reschedules Q4 report to allow additional time for audit »

Craft Brew Alliance…

BREW

Craft Brew

$15.60

-0.25 (-1.58%)

BUD

AB InBev

$108.76

-0.4 (-0.37%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

GLPG

Galapagos NV

$69.96

0.3 (0.43%)

18:17
02/23/17
02/23
18:17
02/23/17
18:17
Hot Stocks
Galapagos doses first healthy volunteer with CF combo GLPG2222, GLPG2451 »

Galapagos announces…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Mar

RH

Restoration Hardware

$25.19

-0.82 (-3.15%)

, SENS

Senseonics

18:15
02/23/17
02/23
18:15
02/23/17
18:15
Hot Stocks
On The Fly: After Hours Movers »

UP AFTER EARNINGS: RH…

RH

Restoration Hardware

$25.19

-0.82 (-3.15%)

SENS

Senseonics

OLED

Universal Display

$67.45

-3.8 (-5.33%)

JWN

Nordstrom

$43.94

-1.41 (-3.11%)

EBS

Emergent BioSolutions

$29.78

-0.14 (-0.47%)

STMP

Stamps.com

$133.75

-0.7 (-0.52%)

MELI

MercadoLibre

$199.82

-0.59 (-0.29%)

BIDU

Baidu

$184.64

-1.37 (-0.74%)

HLF

Herbalife

$59.40

-1.34 (-2.21%)

GPS

Gap

$23.97

-0.9 (-3.62%)

AXDX

Accelerate Diagnostics

$24.75

0.3 (1.23%)

INCY

Incyte

$121.95

0.59 (0.49%)

DDS

Dillard's

$54.68

-0.56 (-1.01%)

NUS

Nu Skin

$47.22

-0.51 (-1.07%)

CONE

CyrusOne

$47.65

-0.08 (-0.17%)

CXW

CoreCivic

$34.00

-0.5 (-1.45%)

GEO

Geo Group

$47.37

-0.38 (-0.80%)

SRPT

Sarepta

$30.15

-0.23 (-0.76%)

ACIA

Acacia Communications

$63.43

1.21 (1.94%)

ZOES

Zoe's Kitchen

$22.46

-0.34 (-1.49%)

ACHC

Acadia

$43.24

0.6 (1.41%)

BGS

B&G Foods

$46.90

-0.65 (-1.37%)

SPLK

Splunk

$64.90

-0.08 (-0.12%)

HPE

HP Enterprise

$24.66

-0.12 (-0.48%)

ACHN

Achillion

$4.24

0.04 (0.95%)

PFGC

Performance Food Group

$24.35

0.4 (1.67%)

NAO

Nordic American Offshore

$2.05

-0.05 (-2.38%)

CELG

Celgene

$119.46

0.19 (0.16%)

HCLP

Hi-Crush Partners

$20.55

-1.4 (-6.38%)

SWN

Southwestern Energy

$8.35

-0.22 (-2.57%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 23

    Feb

  • 23

    Feb

  • 23

    Feb

  • 23

    Feb

  • 23

    Feb

  • 23

    Feb

  • 23

    Feb

  • 23

    Feb

  • 23

    Feb

  • 23

    Feb

  • 23

    Feb

  • 23

    Feb

  • 23

    Feb

  • 23

    Feb

  • 24

    Feb

  • 24

    Feb

  • 24

    Feb

  • 27

    Feb

  • 28

    Feb

  • 28

    Feb

  • 01

    Mar

  • 03

    Mar

  • 06

    Mar

  • 06

    Mar

  • 14

    Mar

  • 19

    Mar

  • 22

    Mar

  • 23

    Mar

  • 24

    Mar

  • 28

    Mar

  • 01

    Apr

  • 04

    Apr

  • 05

    Apr

  • 19

    Apr

  • 24

    Feb

  • 24

    Feb

  • 24

    Feb

COF

Capital One

$93.41

0.52 (0.56%)

18:11
02/23/17
02/23
18:11
02/23/17
18:11
Hot Stocks
Capital One: DOJ, Treasury, New York probing anti-money laundering program »

Capital One disclosed in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

XOM

Exxon Mobil

$81.78

0.85 (1.05%)

18:07
02/23/17
02/23
18:07
02/23/17
18:07
Hot Stocks
New Exxon Mobil CEO: 'Climate risks warrant action' »

New Exxon Mobil CEO…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LNT

Alliant Energy

$39.11

0.46 (1.19%)

18:04
02/23/17
02/23
18:04
02/23/17
18:04
Earnings
Alliant Energy sees FY17 EPS $1.92-$2.06, consensus $2.00 

Sees FY17 CapEx $1.4B.

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Feb

  • 28

    Feb

LNT

Alliant Energy

$39.11

0.46 (1.19%)

18:02
02/23/17
02/23
18:02
02/23/17
18:02
Earnings
Alliant Energy reports Q4 EPS 28c, consensus 28c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Feb

  • 28

    Feb

STZ

Constellation Brands

$153.60

-6.6 (-4.12%)

17:57
02/23/17
02/23
17:57
02/23/17
17:57
Hot Stocks
Constellation Brands says 'ready to act' in any border tax situation »

Sees over $1B in free…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

CONE

CyrusOne

$47.65

-0.08 (-0.17%)

, CLC

Clarcor

$82.96

-0.02 (-0.02%)

17:53
02/23/17
02/23
17:53
02/23/17
17:53
Hot Stocks
CyrusOne to replace Clarcor in S&P 400 as of 3/1 open »

S&P 500 constituent…

CONE

CyrusOne

$47.65

-0.08 (-0.17%)

CLC

Clarcor

$82.96

-0.02 (-0.02%)

PH

Parker-Hannifin

$153.70

-2.16 (-1.39%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 23

    Feb

  • 23

    Feb

  • 06

    Mar

DDS

Dillard's

$54.68

-0.56 (-1.01%)

, ISIL

Intersil

17:52
02/23/17
02/23
17:52
02/23/17
17:52
Hot Stocks
Dillard's to replace Intersil in S&P 400 as of 2/28 open »

Renesas Electronics Corp.…

DDS

Dillard's

$54.68

-0.56 (-1.01%)

ISIL

Intersil

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NUS

Nu Skin

$47.22

-0.51 (-1.07%)

, EQY

Equity One

$31.91

0.39 (1.24%)

17:50
02/23/17
02/23
17:50
02/23/17
17:50
Hot Stocks
Breaking Hot Stocks news story on Nu Skin, Equity One »

Nu Skin to replace Equity…

NUS

Nu Skin

$47.22

-0.51 (-1.07%)

EQY

Equity One

$31.91

0.39 (1.24%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Feb

ENDP

Endo

$13.39

0.5 (3.88%)

, REG

Regency Centers

$70.95

0.94 (1.34%)

17:49
02/23/17
02/23
17:49
02/23/17
17:49
Hot Stocks
Breaking Hot Stocks news story on Endo, Regency Centers »

Endo to replace Regency…

ENDP

Endo

$13.39

0.5 (3.88%)

REG

Regency Centers

$70.95

0.94 (1.34%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Feb

  • 28

    Feb

  • 13

    Mar

  • 14

    Mar

REG

Regency Centers

$70.95

0.94 (1.34%)

, ENDP

Endo

$13.39

0.5 (3.88%)

17:48
02/23/17
02/23
17:48
02/23/17
17:48
Hot Stocks
Regency Centers to replace Endo in S&P 500 as of 3/2 open »

Regency Centers (REG) is…

REG

Regency Centers

$70.95

0.94 (1.34%)

ENDP

Endo

$13.39

0.5 (3.88%)

EQY

Equity One

$31.91

0.39 (1.24%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Feb

  • 24

    Feb

  • 28

    Feb

  • 13

    Mar

  • 14

    Mar

PBI

Pitney Bowes

$13.81

-0.02 (-0.14%)

, CBOE

CBOE Holdings

$80.26

-0.28 (-0.35%)

17:46
02/23/17
02/23
17:46
02/23/17
17:46
Hot Stocks
Breaking Hot Stocks news story on Pitney Bowes, CBOE Holdings »

Pitney Bowes to replace…

PBI

Pitney Bowes

$13.81

-0.02 (-0.14%)

CBOE

CBOE Holdings

$80.26

-0.28 (-0.35%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

CBOE

CBOE Holdings

$80.26

-0.28 (-0.35%)

, PBI

Pitney Bowes

$13.81

-0.02 (-0.14%)

17:45
02/23/17
02/23
17:45
02/23/17
17:45
Hot Stocks
CBOE Holdings to repplace Pitney Bowes in S&P 500 as of 3/1 open »

CBOE (CBOE) is acquiring…

CBOE

CBOE Holdings

$80.26

-0.28 (-0.35%)

PBI

Pitney Bowes

$13.81

-0.02 (-0.14%)

BATS

Bats Global Markets

$35.65

-0.08 (-0.22%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Mar

INCY

Incyte

$121.95

0.59 (0.49%)

, SE

Spectra Energy

$41.00

-0.31 (-0.75%)

17:42
02/23/17
02/23
17:42
02/23/17
17:42
Hot Stocks
Incyte to replace Spectra Energy in S&P 500 as of 2/28 open »

Spectra Energy (SE) is…

INCY

Incyte

$121.95

0.59 (0.49%)

SE

Spectra Energy

$41.00

-0.31 (-0.75%)

ENB

Enbridge

$41.71

-0.44 (-1.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Mar

  • 06

    Mar

  • 14

    Mar

  • 01

    Apr

  • 19

    Apr

STMP

Stamps.com

$133.75

-0.7 (-0.52%)

17:41
02/23/17
02/23
17:41
02/23/17
17:41
Earnings
Stamps.com reports Q4 EPS $2.73, consensus $2.36 »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INCY

Incyte

$121.95

0.59 (0.49%)

, CBOE

CBOE Holdings

$80.26

-0.28 (-0.35%)

17:39
02/23/17
02/23
17:39
02/23/17
17:39
Hot Stocks
Breaking Hot Stocks news story on Incyte, CBOE Holdings, Regency Centers »

Incyte, CBOE Holdings,…

INCY

Incyte

$121.95

0.59 (0.49%)

CBOE

CBOE Holdings

$80.26

-0.28 (-0.35%)

REG

Regency Centers

$70.95

0.94 (1.34%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Feb

  • 06

    Mar

  • 14

    Mar

  • 01

    Apr

  • 19

    Apr

MTZ

MasTec

$37.05

-0.45 (-1.20%)

17:36
02/23/17
02/23
17:36
02/23/17
17:36
Earnings
MasTec sees Q1 adjusted EPS 51c, consensus 23c »

Sees Q1 revenue $1.05B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Feb

MTZ

MasTec

$37.05

-0.45 (-1.20%)

17:36
02/23/17
02/23
17:36
02/23/17
17:36
Earnings
MasTec sees FY17 adjusted EPS $2.35, consensus $2.09 »

Sees FY17 revenue $5.5B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Feb

GOOG

Alphabet

$831.33

0.57 (0.07%)

, GOOGL

Alphabet Class A

$851.00

-0.36 (-0.04%)

17:35
02/23/17
02/23
17:35
02/23/17
17:35
Periodicals
Breaking Periodicals news story on Alphabet, Alphabet Class A »

Alphabet's Waymo…

GOOG

Alphabet

$831.33

0.57 (0.07%)

GOOGL

Alphabet Class A

$851.00

-0.36 (-0.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 06

    Mar

  • 19

    Mar

MTZ

MasTec

$37.05

-0.45 (-1.20%)

17:34
02/23/17
02/23
17:34
02/23/17
17:34
Earnings
MasTec reports Q4 adjusted EPS 70c, consensus 54c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Feb

SSRI

Silver Standard

$10.90

-0.06 (-0.55%)

17:34
02/23/17
02/23
17:34
02/23/17
17:34
Earnings
Silver Standard reports Q4 adjusted EPS 26c, consensus 18c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Feb

ALJ

Alon USA Energy

$11.73

0.17 (1.47%)

17:34
02/23/17
02/23
17:34
02/23/17
17:34
Earnings
Alon USA Energy reports Q4 EPS ex-items (20c), consensus (33c) »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Feb

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.